Hybridoma Cell Line G7 Producing Monoclonal Anti-mouse CD90 (Thy-1) Antibody
A hybridoma cell line producing a monoclonal rat antibody specific to mouse CD90 (Thy-1) (clone G7) as described in J Exp Med. 1984 Mar 1;159(3):716-30 and developed by the laboratory of Dr. Ethan Shevach at the National Institute of Allergy and Infectious Diseases.
Potential Commercial Applications: | Competitive Advantages: |
|
|
Inventors:
Ethan Shevach (NIAID) ➽ more inventions...
Intellectual Property:
Research Material – Patent protection is not being pursued for this technology. (IC Reference No. 1948-254)
Publications:
Gunter KC, et al. PMID 6142077
Licensing Contact:
Yogikala Prabhu,
Email: prabhuyo@niaid.nih.gov
Phone: 301-761-7789
OTT Reference No: B-004-1991-4
Updated: Dec 4, 2017